SecBot SecBot
424B5 ·Filed Aug 27, 2026

GRML

Greenland Mines Ltd
BEARISH
Impact 7/10
Horizonimmediate Processed2mo ago SEC0001213900-26-094216
Notable filing: 424B5
Actionable Insight ▼ Bearish

The deep discount offering signals urgent capital needs and will pressure the stock toward the $5.00 offering price. Monitor for the actual number of shares sold (best-efforts, no minimum) and any updates on the Neo North Star merger closing. The September 14, 2026 Nasdaq bid-price compliance deadline is a critical catalyst — failure to maintain $1.00 could trigger delisting and further downside.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
GRML ▲ +212.27% at T+20d
SHORT call ✗ call lost -212.27% · α vs SPY -212.37% · entry $5.26 → $16.43
Next anchor: T+60d in 24d
Entry = T+0 close
Aug 27, 2026
via day close
T+1d
-7.22%
call +7.22% · α +7.00%
$4.88
settled 2mo ago
T+5d
-7.41%
call +7.41% · α +6.64%
$4.87
settled 8w ago
T+20d
+212.27%
call -212.27% · α -212.37%
$16.43
settled 5w ago
T+60d
Pending
in 24d

Price Chart

Loading chart...

Executive Summary

Greenland Mines Ltd is conducting a best-efforts offering of up to 4,000,000 shares of common stock and/or pre-funded warrants at $5.00 per share, targeting gross proceeds of up to $20 million. The offering price represents a 41.5% discount to the last closing price of $8.55 on August 24, 2026, and the net proceeds of ~$18.6 million are earmarked for the $35 million acquisition of the Sarfartoq project. The filing is bearish due to severe dilutive impact (immediate dilution of $1.14 per share to new investors, or ~23% of offering price), a massive overhang from 40.8 million shares issuable upon Series C Preferred conversion, and ongoing Nasdaq bid-price compliance risk with a September 14, 2026 deadline.

Key Facts

  • Offering of up to 4,000,000 shares/pre-funded warrants at $5.00/share, a 41.5% discount to the $8.55 last sale price on August 24, 2026.
  • Maximum gross proceeds of $20 million; net proceeds to company ~$18.6 million after 7% placement agent fees and expenses.
  • Proceeds intended for the $35 million acquisition of the Sarfartoq project via the Neo North Star merger ($20M cash + $15M stock).
  • Pro forma shares outstanding after offering (assuming full warrant exercise) would be 7,177,013, up from 3,177,013 pre-offering.
  • Immediate dilution of $1.14 per share to new investors; pro forma net tangible book value of $3.86 vs. offering price of $5.00.
  • Massive potential dilution from 40,800,776 shares issuable upon conversion of Series C Preferred stock.
  • Company faces Nasdaq delisting risk if it fails to regain compliance with the $1.00 bid price rule by September 14, 2026.
  • Best-efforts offering with no minimum; actual proceeds may be substantially less than the maximum.
  • 30-day lock-up on directors and officers; 30-day standstill on further equity issuances.

Financial Impact

Up to $20 million gross proceeds; net proceeds ~$18.6 million. Immediate dilution of $1.14 per share (23% of offering price). Pro forma shares outstanding increase by 126% to 7,177,013.

dilutionshare countcash positionbook value

Risk Factors

  • Offering at 41.5% discount to last close creates immediate downward price pressure.
  • No minimum offering amount — company may raise far less than needed, leaving the Neo North Star acquisition unfunded.
  • Massive overhang from 40.8M Series C Preferred shares (13x current float) caps any upside.
  • Nasdaq delisting risk by September 14, 2026 if bid price fails to stay above $1.00.
  • Best-efforts structure with no escrow means investor funds are at risk even if the offering is undersubscribed.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001213900-26-094216
Document: 0001213900-26-094216-index-headers.html0001213900-26-094216
Document: 0001213900-26-094216-index.html0001213900-26-094216
Document: 0001213900-26-094216.txt0001213900-26-094216
27 reports for GRML
Performance horizon
79% Hit rate @ T+1 11 of 14 directional calls Went positive at some point 12 of 14 best @ T+20▲ +65.50%Aug 24, 2026
Filters
Rows
Reports for GRML — sortable, filterable
TypeNow
Oct 26, 2026
today
S-1
NEUTRAL ★ 4/10
$5.76awaiting T+1—$5.78 (+0.33%)
Oct 6, 2026
20d ago
Press Release
NEUTRAL ★ 4/10
$6.38 $5.83▼ −8.62%▼ −8.38%$5.78 (−9.40%)
Oct 5, 2026
21d ago
Press Release
NEUTRAL ★ 4/10
$7.34 $6.38▼ −13.08%▼ −13.63%$5.78 (−21.25%)
Sep 24, 2026
4w ago
Press Release
BEARISH ★ 6/10
$14.89 $14.66▲ +1.54%▲ +2.09%$5.78 (+61.18%)
Sep 23, 2026
4w ago
424B5
BEARISH ★ 6/10
$14.89 $14.66▲ +1.54%▲ +2.09%$5.78 (+61.18%)
Sep 23, 2026
4w ago
8-K
BEARISH ★ 6/10
$14.89 $14.66▲ +1.54%▲ +2.09%$5.78 (+61.18%)
Sep 23, 2026
4w ago
424B5
BULLISH ★ 4/10
$11.19 $14.89▲ +33.07%▲ +33.15%$5.78 (−48.35%)
Sep 23, 2026
4w ago
Press Release
NEUTRAL ★ 2/10
$11.19 $14.89▲ +33.07%▲ +33.15%$5.78 (−48.35%)
Sep 22, 2026
4w ago
Institutional Cluster
NEUTRAL ★ 2/10
$14.15 $11.19▼ −20.92%▼ −20.20%$5.78 (−59.15%)
Sep 21, 2026
5w ago
Press Release
NEUTRAL ★ 5/10
$9.42 $14.15▲ +50.21%▲ +50.23%$5.78 (−38.64%)
Showing 10 of 27

US Market Status

Market Closed — Opens Wed (11h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 27, 2026